{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:49:23Z","timestamp":1786121363355,"version":"build-2736575974"},"reference-count":47,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study investigated the associations of serum 25-hydroxyvitamin D [25(OH)D], the principal circulating marker used to assess vitamin D status, and chemerin with metabolic syndrome (MetS) components in individuals with type 2 diabetes mellitus (T2DM) and in a non-diabetic comparison group. The MetS components assessed were central obesity\/waist circumference, blood pressure, fasting plasma glucose, triglycerides, and HDL-C, because these are the diagnostic elements of the International Diabetes Federation (IDF) definition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional analytical study was conducted at King Abdulaziz University, Rabigh, between August 2021 and December 2022. Participants were classified as having MetS according to IDF criteria, and vitamin D status was classified using serum 25(OH)D concentrations as deficient, insufficient, or sufficient. Serum 25(OH)D, chemerin, and CRP were measured by ELISA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 176 participants were included in the study (88 with diabetes and 88 non-diabetic comparison participants), with equal sex distribution in both groups (44 females and 44 males per group). Compared with the non-diabetic comparison group, participants with T2DM had significantly higher chemerin (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001) and significantly lower 25(OH)D (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). The MetS was more common in diabetic participants than in non-diabetic comparison participants: 70\/88 (79.5%) vs. 43\/88 (48.9%) (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). Blood chemerin levels were also elevated in those with MetS compared with those without MetS (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.032). Within the diabetic group, 18\/88 (20.5%) had 25(OH)D deficiency and 47\/88 (53.4%) had insufficient levels, whereas among non-diabetic comparison participants, 7\/88 (8%) had deficiency and 32\/88 (36.4%) had insufficient levels (\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt; 0.001). Higher FPG, insulin, HOMA-IR, HbA1c, TC, and CRP were associated with lower 25(OH)D in diabetic subjects. The latter inverse relationships were also observed in the MetS subgroup. Chemerin was associated with HOMA-IR, FPG, TC, CRP, and HbA1c in diabetic subjects. In the MetS subgroup, FPG, insulin, HOMA-IR, HbA1c, TC, and CRP remained positively correlated with chemerin. The regression analysis revealed that diabetic status and female sex were independently related to 25(OH)D status. In the adjusted chemerin model, chemerin was inversely and significantly associated with 25(OH)D (B \u22122.451, 95% CI \u22123.916\u2013\u22120.986,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). Diabetes and female sex were the only variables independently associated with MetS status in the logistic regression analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Individuals with T2DM showed lower serum 25(OH)D and increased chemerin concentrations than non-diabetic comparison participants. Chemerin was higher in participants with MetS, whereas neither 25(OH)D nor chemerin was independently associated with MetS in the adjusted logistic model. These findings support an association, rather than a causal or diagnostic relationship, between 25(OH)D, chemerin, and cardiometabolic disturbance in this cohort. Further longitudinal and interventional studies are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1907839","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:22:28Z","timestamp":1786076548000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of 25-hydroxyvitamin D and chemerin with metabolic syndrome components in individuals with type 2 diabetes mellitus"],"prefix":"10.3389","volume":"13","author":[{"given":"Mukhtiar","family":"Baig","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry and Medical Education, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohair Jamil","family":"Gazzaz","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University","place":["Rabigh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad Nidal","family":"Khabaz","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, King Abdulaziz University","place":["Rabigh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahad Abduljalil","family":"Abualhamael","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University","place":["Rabigh, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami Hamdan","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Department of Family Medicine, Faculty of Medicine, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]},{"name":"Health Promotion Center, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wail A.","family":"Alamoudi","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, King Abdulaziz University","place":["Rabigh, Saudi Arabia"]},{"name":"Family Medicine and Chronic Diseases Research Unit, King Fahd Medical Research Center, King Abdulaziz University","place":["Jeddah, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,7]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1380244","DOI":"10.3389\/fcdhc.2024.1380244","article-title":"Metabolic syndrome and pharmacotherapy outcomes in patients with type 2 diabetes mellitus","volume":"5","author":"Alawdi","year":"2024","journal-title":"Front Clin Diabetes Healthc."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1016\/j.cell.2021.02.012","article-title":"Metabolic consequences of obesity and type 2 diabetes: balancing genes and environment for personalized care","volume":"184","author":"Pillon","year":"2021","journal-title":"Cell."},{"key":"B3","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1038\/s41598-020-59203-z","article-title":"Changes in metabolic syndrome and its components and the risk of type 2 diabetes: a nationwide cohort study","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/sjmms.sjmms_394_22","article-title":"Prevalence of type 2 diabetes mellitus in the general population of Saudi Arabia, 2000\u20132020: a systematic review and meta-analysis of observational studies","volume":"11","author":"Jarrar","year":"2023","journal-title":"Saudi J Med Med Sci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.15537\/smj.2021.42.5.20200676","article-title":"Prevalence and reasons of increased type 2 diabetes in Gulf Cooperation Council Countries","volume":"42","author":"Aljulifi","year":"2021","journal-title":"SMJ."},{"key":"B6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s13098-020-00575-7","article-title":"Relationship of metabolic syndrome defined by IDF or revised NCEP ATP III with glycemic control among Malaysians with type 2 diabetes","volume":"12","author":"Saif-Ali","year":"2020","journal-title":"Diabetol Metab Syndr."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/235101","article-title":"Prevalence of cardiovascular disease and associated risk factors among adult population in the gulf region: a systematic review","volume":"2015","author":"Aljefree","year":"2015","journal-title":"Adv Public Health."},{"key":"B8","doi-asserted-by":"publisher","first-page":"973","DOI":"10.15537\/smj.2023.44.10.20230450","article-title":"Understanding the prevalence, progression, and management of metabolic syndrome in Saudi Arabia","volume":"44","author":"Alshehri","year":"2023","journal-title":"SMJ."},{"key":"B9","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s13410-022-01066-3","article-title":"Association of serum level of chemerin with visceral fat obesity in type 2 diabetic patient","volume":"43","author":"Qazi","year":"2023","journal-title":"Int J Diabetes Dev Ctries."},{"key":"B10","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.3390\/ijms21186644","article-title":"The molecular mechanisms by which Vitamin D prevents insulin resistance and associated disorders","volume":"21","author":"Szymczak-Pajor","year":"2020","journal-title":"IJMS."},{"key":"B11","doi-asserted-by":"publisher","first-page":"117305","DOI":"10.1016\/j.lfs.2020.117305","article-title":"The molecular mechanisms by which vitamin D improve glucose homeostasis: a mechanistic review","volume":"244","author":"Yaribeygi","year":"2020","journal-title":"Life Sci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cca.2021.02.010","article-title":"Chemerin in inflammatory diseases","volume":"517","author":"Su","year":"2021","journal-title":"Clinica Chimica Acta."},{"key":"B13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11906-025-01354-3","article-title":"Chemerin as a mediator of hypertension and cardiometabolic diseases (a comprehensive review)","volume":"28","author":"McMillan","year":"2025","journal-title":"Curr Hypertens Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3390\/biomedicines12050983","article-title":"Chemerin levels in individuals with type 2 diabetes and a normal weight versus individuals with type 2 diabetes and obesity: an observational, cross-sectional study","volume":"12","author":"Mukherji","year":"2024","journal-title":"Biomedicines."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.3390\/nu15132878","article-title":"The role of chemerin in metabolic and cardiovascular disease: a literature review of its physiology and pathology from a nutritional perspective","volume":"15","author":"Tan","year":"2023","journal-title":"Nutrients."},{"key":"B16","doi-asserted-by":"publisher","first-page":"794","DOI":"10.3390\/nu11040794","article-title":"Analysis of association between vitamin D deficiency and insulin resistance","volume":"11","author":"Szymczak-Pajor","year":"2019","journal-title":"Nutrients."},{"key":"B17","doi-asserted-by":"publisher","first-page":"111504","DOI":"10.1016\/j.mce.2021.111504","article-title":"G\u00f3mez- Garc\u00eda I, Portillo MP. Role of chemerin in the control of glucose homeostasis","volume":"541","author":"L\u00e9niz","year":"2022","journal-title":"Mol Cell Endocrinol."},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-59627-z.","article-title":"Principal component analysis of adipokine, metabolic, oxidative, and inflammatory markers associated with insulin resistance in metabolic syndrome","author":"Hamedi-Shahraki","year":"2026","journal-title":"Sci Rep."},{"key":"B19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. a consensus statement from the international diabetes federation diabetic","volume":"23","author":"Alberti","year":"2006","journal-title":"Medicine."},{"key":"B20","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"B21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.annepidem.2007.12.001","article-title":"Vitamin D status: measurement, interpretation, and clinical application","volume":"19","author":"Holick","year":"2009","journal-title":"Ann Epidemiol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.36346\/sarjps.2023.v05i04.010","article-title":"Evaluation of vitamin D in patients with type 2 diabetes mellites","volume":"5","author":"Ahmed","year":"2023","journal-title":"South Asian Res J Pharm Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"39","DOI":"10.24293\/ijcpml.v30i1.2069","article-title":"Analysis of serum chemerin levels in type 2 diabetes mellitus patients","volume":"30","author":"Fauziah","year":"2023","journal-title":"Indonesian J Clin Pathol Med Lab."},{"key":"B24","doi-asserted-by":"publisher","first-page":"442","DOI":"10.4183\/aeb.2019.442","article-title":"Irisin and Chemerin levels in patients with type 2 diabetes mellitus","volume":"15","author":"Balaban","year":"2019","journal-title":"Acta Endo."},{"key":"B25","first-page":"1296","article-title":"Relationship of serum novel adipokine chemerin levels with body composition, insulin resistance, dyslipidemia and diabesity in Saudi women","volume":"21","author":"Habib","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/ijnpnd.ijnpnd_61_21","article-title":"Vitamin D status of type 2 diabetic patients in Oujda North-East Morocco","volume":"12","author":"Hsaini","year":"2022","journal-title":"Int J Nutr Pharmacol Neurol Dis."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.12688\/f1000research.125191.1","article-title":"Impact of serum levels of vitamin D on lipid profiles, glycemic indices, and insulin resistance in obese type 2 diabetes patients: an observational study","volume":"11","author":"Faris Raheem","year":"2022","journal-title":"F1000Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5455\/jib.20170915112339","article-title":"Synergistic role of vitamin D and adipocytokines in etiology of diabetes in Kashmiri population","volume":"6","author":"Din","year":"2017","journal-title":"J Invest Biochem."},{"key":"B29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.62940\/als.v11i2.2490","article-title":"Association between vitamin D levels and insulin resistance in patients with type 2 diabetes mellitus","volume":"11","author":"Abdulmajeed Arif","year":"2024","journal-title":"Adv life sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.3390\/jcm13051390","article-title":"Vitamin D\u2014a new therapeutic target in the management of type 2 diabetes patients","volume":"13","author":"Albai","year":"2024","journal-title":"JCM."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e68689","DOI":"10.1371\/journal.pone.0068689","article-title":"Hypovitaminosis D is independently associated with metabolic syndrome in obese patients","volume":"8","author":"Barchetta","year":"2013","journal-title":"PLoS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e0175388","DOI":"10.1371\/journal.pone.0175388","article-title":"Vitamin D status and its association with insulin resistance among type 2 diabetics: A case -control study in Ghana","volume":"12","author":"Fondjo","year":"2017","journal-title":"PLoS ONE."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1080138","DOI":"10.3389\/fendo.2023.1080138","article-title":"Hamedi\u2013Shahraki S, Rahimlou M. Vitamin D insufficiency and its association with adipokines and atherogenic indices in patients with metabolic syndrome: a case-control study","volume":"14","author":"Amirkhizi","year":"2023","journal-title":"Front Endocrinol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.bjbas.2013.02.001","article-title":"Chemerin is associated with markers of inflammation and predictors of atherosclerosis in Saudi subjects with metabolic syndrome and type 2 diabetes mellitus","volume":"2","author":"Ali","year":"2013","journal-title":"Beni-Suef Univ J Basic Appl Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.3349\/ymj.2017.58.2.319","article-title":"Serum chemerin levels are associated with visceral adiposity, independent of waist circumference, in newly diagnosed type 2 diabetic subjects","volume":"58","author":"Cheon","year":"2017","journal-title":"Yonsei Med J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e113915","DOI":"10.1371\/journal.pone.0113915","article-title":"Association between serum chemerin concentrations and clinical indices in obesity or metabolic syndrome: a meta-analysis","volume":"9","author":"Li","year":"2014","journal-title":"PLoS ONE."},{"key":"B37","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s43042-020-00063-7","article-title":"The associations among RARRES2 rs17173608 gene polymorphism, serum chemerin, and non-traditional lipid profile in patients with metabolic syndrome","volume":"21","author":"Dahpy","year":"2020","journal-title":"Egypt J Med Hum Genet."},{"key":"B38","doi-asserted-by":"publisher","first-page":"409","DOI":"10.29252\/ijwph.14.4.409","article-title":"Evaluation of chemerin in diabetic type 2 patients with metabolic syndrome in both gender","volume":"14","author":"AlHusaini","year":"2022","journal-title":"Iran J War Public Health."},{"key":"B39","author":"Tirtha Raj","year":"","journal-title":"Study of serum adiponectin, leptin and chemerin levels in patients with type 2 diabetes mellitus and obesity"},{"key":"B40","first-page":"191","article-title":"The adipokine chemerin and fetuin-a serum levels in type 2 diabetes mellitus: relation to obesity and inflammatory markers","volume":"25","author":"El-Deeb","year":"2018","journal-title":"Egypt J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"735","DOI":"10.3390\/jpm12050735","article-title":"Differential association of selected adipocytokines, adiponectin, leptin, resistin, visfatin and chemerin, with the pathogenesis and progression of type 2 diabetes mellitus (T2DM) in the Asir region of Saudi Arabia: a case control study","volume":"12","author":"Mir","year":"2022","journal-title":"JPM."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.3390\/biomedicines13112619","article-title":"Investigation of serum visfatin and chemerin levels in type 2 diabetes and obesity patients: their potential role as clinical and biomarkers","volume":"13","author":"Yilmaz","year":"2025","journal-title":"Biomedicines."},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4103\/aam.aam_630_25","article-title":"Correlation of adipokines (omentin-1 and chemerin) in type 2 diabetes mellitus with metabolic syndrome patients: a case\u2013control study","author":"Pandey","year":"2026","journal-title":"Ann Afr Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/ca\/2026\/v15i1521","article-title":"Study of association between serum chemerin and cardio-predictive anthropometric risk factors in type-2 diabetes mellitus population","volume":"15","author":"Imafidon","year":"2026","journal-title":"Cardiol Angiol Int J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1507\/endocrj.EJ12-0201","article-title":"Decreased serum chemerin levels in male Japanese patients with type 2 diabetes: sex dimorphism","volume":"60","author":"Takahashi","year":"2013","journal-title":"Endocr J."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.3892\/etm.2018.5753","article-title":"Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus","volume":"15","author":"Zhang","year":"2018","journal-title":"Exp Ther Med."},{"key":"B47","first-page":"12","article-title":"Molecular insights into adipokines in metabolic syndrome: implications for novel therapeutic strategies","volume":"1","author":"Asghar","year":"2026","journal-title":"Al Najam J Med Life Sci."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1907839\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T04:22:29Z","timestamp":1786076549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1907839\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,7]]},"references-count":47,"alternative-id":["10.3389\/fmed.2026.1907839"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1907839","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,7]]},"article-number":"1907839"}}